Differential contribution of r and s isomers in ketoprofen anti-inflammatory activity: role of cytokine modulation

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 969-974

  Ghezzi, Pietro ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CYTOKINE; KETOPROFEN; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; EDEMA; GUINEA PIG; HYPERALGESIA; MALE; STEREOISOMERISM; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ISOMER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CYTOKINES; DINOPROSTONE; EDEMA; GUINEA PIGS; HYPERALGESIA; KETOPROFEN; LIPOPOLYSACCHARIDES; MALE; STEREOISOMERISM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032247931     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Abas A and Meffin PJ (1987) Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drug. IV. Ketoprofen disposition. J Pharmacol Exp Ther 240:637-641.
2. Aberg G, Ciofalo VB, Pendleton GR, Ray G and Weddle D (1995) Inversion of (R)- to (S)-ketoprofen in eight animal species. Chirality 7:383-387.
3. Adams SS, Bresloff P and Mason CG (1976) Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic inversion of the ( - ) isomer. J Pharm Pharmacol 28:256-257.
4. Aggarwal BB, Knor WJ, Mass PE, Moffat B, Spencer SA, Henzel J, Bringman S, Nedwin GE, Goeddel DV and Harkins RN (1985) Human tumor necrosis factor: Production, purification and characterization. J Biol Chetn 260:2345-2354.
5. Appleyard CB, McCafferty DM, Tigley AW, Swain MG and Wallace JL (1996) Tumor necrosis factor mediation of NSAID-induced gastric damage: Role of leukocyte adherence. Am J Physiol 270:G42-G48.
6. Brune K, Beck WS, Geisslinger G, Menzel-Soglowek S, Peskar BM and Peskar BA ( 1991) Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 47:257-261.
7. Brune K, Geisslinger G and Menzen-Soglowek S (1992) Pure enantiomers of 2-arylpropionic acids: Tools in pain research and improved drugs in rheumatology. J Clin Pharmacol 32:944-952.
8. Brune K, Rainsford KD, Wagner K and Peskar BA (1981) Inhibition by antiinflammatory drugs of prostaglandin production in cultured macrophages. Naunyn-Schmiedeberg's Arch Pharmacol 315:269-278.
9. Cox JW, Cox SR, VanGiessen G and Ruwart MJ (1985) Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver. J Pharmacol Exp Ther 38:636-643.
10. Cunha FQ, Poole S, Lorenzetti BB and Ferreira SH (1992) The pivotal role of tumor necrosis factor a in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660-664.
11. Cuhna FQ, Lorenzetti BB, Poole S and Ferreira SH (1991) Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104:765-767.
12. Elliott MJ, Maini RN, Feldmann M, Kalden JN, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H and Woody JN (1994) Randomised doubleblind comparison of chimeric monoclonal antibody to tumor necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110.
13. Endres S, Whitaker RE, Ghorbani R, Meydani SN and Dinarello CA (1996) Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumor necrosis factor-alpha ex vivo. Immunology 87:264-270.
14. Graham GG, Champion GD, Day RO, Kaski AL, Hills LG and Paull PD (1977) Salycilates in rheumatoid arthritis: Pharmacokinetics and analgesic response. In Aspirin and Related Drugs, ed. by KD Rainsforrd, K Brune and MW Whitehouse. Agents Action Suppl 1:37-42.
15. Hutt AJ and Caldwell J (1983) The metabolic chiral inversion of 2-arylpropionic acids-a novel route with pharmacological consequences. J Pharm Pharmacol 35:693-704.
16. Insel PA (1990) Analgesic-antipyretics and antiinflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout. In The Pharmacological Basis of Therapeutics, ed. by A Goodman Gilman, TW Rail, AS Nies and P Taylor, pp. 638-681, Pergamon Press Inc., New York.
17. Jerussi TP, Caubet J-F, McCray JE and Handley DA (1998) Clinical endoscopie evaluation of the gastroduodenal tolerance to (R)-ketoprofen, (R)-flurbiprofen, racemic ketoprofen, and paracetamol: A randomized, single-blind, placebocontrolled trial. J Clin Pharmacol 38:19S-24S.
18. Jorres A, Dinter H, Topley N, Gahl GM, Frei U and Scholz P (1997) Inhibition of tumor necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: Cellular mechanisms. Cytokine 9:119-125.
19. Knadler MP and Hall SD (1990) Stereoselective arylpropionyl-CoA thioester formation in vitro. Chhirality 2:67-73.
20. Knihinicki RD, Williams KM and Day RO (1989) Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs. I. In vitro studies of ibuprofen and flurbiprofen. Biochem Pharmacol 38:4389-4395.
21. Kunkel SL, Spengler M, May MA, Spengler R, Larrick J and Remick D (1988) Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263:5380-5384.
22. Lanz R, Polster P and Brune K (1986) Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly. Eur J Pharmacol 130:1)5109.
23. Lehmmann V, Benninghoff B and Droge W (1988) Tumor necrosis factor-induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP. J Immunol 141:587-591.
24. Mauleon D, Artigas R, Garcia ML and Carganico G (1996) Preclinical and clinical development of dexketoprofen. Drugs 52:24-46.
25. McCormack K and Brune K (1991) Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. Drugs 41:533-547.
26. McCormack K and Urquhart E (1995) Correlation between nonsteroidal a:itiinflammatory drug efficacy in a clinical pain model and the dissociation of their anti-inflammatory and analgesic properties in animal models. Clin Drug Invest 9:88-97.
27. Menzel-Soglowek S, Geisslinger G, Mollenhauer J and Brune K (1992) Metabolic chiral inversion of 2-arylpropionates in rat H4ITE and human HEP G2 hepatcma cells. Biochem Pharmacol 43:1487-1492.
28. Muller S, Mayer JM, Etter JC and Testa B (1990) Metabolic chiral inversior. of ibuprofen in isolated rat hepatocytes. Chirallty 2:74-78.
29. Otterness IG and Bliven ML (1985) Laboratory models for testing non-steroidal antiinflammatory drugs. In Nonsteroidal Antiinflammatory Drugs, ed. by JG Lombardino, pp. 112-252, John Wiley & Sons, New York.
30. Pettipher ER and Wtmberly DJ (1994) Cyclooxygenase inhibitors enhance tumor necrosis factor production and mortality in murine endotoxic shock. Cytokine 6:500-503.
31. Randall RO and Selitto JJ (1957) A method for measurement of analgesic activity of inflamed tissues. Arch Int Pharmacodyn 111:409-412.
32. Renz H, Gong JH, Schmidt A, Nain M and Gemsa D (1988) Release of tumor necrosis factor-a from macrophages: Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 141:2388-2393.
33. Sanins SM, Adams WJ, Kaiser DG, Halstead GW and Baillie TA (1990) Studies on the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes. Drug Metab Dispos 18:527-533.
34. Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di Matteo FM and Morelli A (1994) Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: Role of tumor necrosis factor-a. Gut 35:909-915.
35. Sironi M, Gadina M, Kankova M, Riganti F, Mantovani A, Zandalasini M and Ght'zzi P (1992) Differential sensitivity of in vivo TNF and IL-6 production to modulation by antiinflammatory drugs in mice. Int J Immunopharmacol 14:1045-1050.
36. Stack WA, Mann SD, Roy AJ, Heath P, Sopwith M, Freedman J, Holme G, Long R, Forbes A, Kamm MA and Hawkey CJ (1997) Randomised controlled trial of CDP571 antibody to tumor necrosis factor-a in Crohn's disease. Lancet 349:5!il- 524.
37. Strassmann G, Patil-Koota V, Finkelman F, Fong M and Kambayashi T (1994) Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med 180:2365-2370.
38. Tannenbaum CS and Hamilton TA (1989) Lipopolysaccharide-induced gene expres-sion in murine peritoneal macrophages is selectively suppressed by agents t aat elevate intracellular cAMP. J Immunol 142:1274-1280
39. Tsuboi 1, Tanaka H, Nakao M, Shichijo S and Itoh K (1995) Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lympho-cytes: Up-regulatiori of TNF, IFN-y and IL-2, in contrast to down-regulation of IL-6 production. Cytokine 7:372-379.
40. Tsukada W, Tsubokawa M, Kojima H and Kasahra A (1978) Pharmacological study of 6,ll-dihydro-ll-oxodibenz(b,e)oxepin-3-acetic acid (oxepinac): A new anfrin- flammatory drug. Arzneim Forsch Drug Res 28:428-438.
41. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirine-like drugs. Nature 231:232-235.
42. Williams KM (1990) Enantiomers in arthritic disorders. Pharmacol Ther 46:2"3- 295.
43. Winter CA, Risley EA and Nus GV (1963) Carrageenan-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544-547